Royal Marsden NHS Foundation Trust
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
PembRolIzuMab and Stereotactic Body Radiotherapy In Metastatic Non-small-cell lunG Cancer Patients
Phase 1
Terminated
- Conditions
- Metastatic Non-small-cell lunG Cancer
- Interventions
- Radiation: Stereotactic Body Radiotherapy (SBRT) 30 Gy 3 fractions (#)Radiation: Stereotactic Body Radiotherapy (SBRT) 54 Gy 3 fractions (#)Radiation: Stereotactic Body Radiotherapy (SBRT) dosed at the maximum tolerated dose
- First Posted Date
- 2018-02-19
- Last Posted Date
- 2022-09-09
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 2
- Registration Number
- NCT03436056
- Locations
- 🇬🇧
Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
MR-guided RAdiotherapy to Breast With Dose Escalation to regionaL Lymph NodEs
Not Applicable
Completed
- Conditions
- Breast Cancer
- Interventions
- Procedure: Radiotherapy planning using both CT and MRI scans
- First Posted Date
- 2018-01-23
- Last Posted Date
- 2020-08-17
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 1
- Registration Number
- NCT03405519
- Locations
- 🇬🇧
The Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
Study Title: Peri-operative Immuno-Chemotherapy in Operable Oesophageal and Gastric Cancer
Phase 2
Active, not recruiting
- Conditions
- Gastric AdenocarcinomaOesophageal Adenocarcinoma
- Interventions
- Drug: FLOT-A
- First Posted Date
- 2018-01-16
- Last Posted Date
- 2023-02-21
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 44
- Registration Number
- NCT03399071
- Locations
- 🇬🇧
The Royal Marsden Hospital, London, United Kingdom
SBRT With Immunotherapy in Early Stage Non-small Cell Lung Cancer: Tolerability and Lung Effects
Phase 1
Active, not recruiting
- Conditions
- Non-small Cell Lung Cancer Stage IINon-small Cell Lung Cancer Stage I
- Interventions
- Radiation: Stereotactic body radiotherapy
- First Posted Date
- 2017-12-26
- Last Posted Date
- 2024-02-22
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 29
- Registration Number
- NCT03383302
- Locations
- 🇬🇧
Royal Marsden Hospital, Sutton, United Kingdom
Lab-on-a-chip Detection of Cervical Cancer Tumour Markers
- Conditions
- Cervical Cancer
- Interventions
- Diagnostic Test: Tumour markers detection
- First Posted Date
- 2017-12-21
- Last Posted Date
- 2017-12-21
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 50
- Registration Number
- NCT03380741
Combination Nab-paclitaxel (N-P) and Nintedanib or N-P and Placebo in Relapsed NSCLC Adenocarcinoma
Phase 1
Withdrawn
- Conditions
- NSCLC, RecurrentAdenocarcinoma of Lung
- Interventions
- First Posted Date
- 2017-12-04
- Last Posted Date
- 2020-11-24
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Registration Number
- NCT03361319
Enhancing Diagnosis in Chronic B-cell Lymphoproliferative Disorders Using Next-Generation Sequencing
Active, not recruiting
- Conditions
- Lymphoma
- First Posted Date
- 2017-11-17
- Last Posted Date
- 2024-04-22
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 127
- Registration Number
- NCT03344809
- Locations
- 🇬🇧
The Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
London Investigation Into diElectric Scanning of Lesions
Not Applicable
- Conditions
- Breast Cancer
- Interventions
- Diagnostic Test: MARIA scan
- First Posted Date
- 2017-10-05
- Last Posted Date
- 2017-10-05
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 994
- Registration Number
- NCT03302819
Blood Immunophenotyping in Staging of Indolent B-cell Lymphomas V1.0
- Conditions
- Marginal Zone Lymphoma (MZL)Follicular Lymphoma (FL)Mantle Cell Lymphoma (MCL)
- First Posted Date
- 2017-08-29
- Last Posted Date
- 2017-08-29
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 108
- Registration Number
- NCT03265158
- Locations
- 🇬🇧
The Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
Simulating Outcomes From Breast Conserving Surgery Using 3D Surface Imaging
Not Applicable
- Conditions
- Breast Cancer Female
- Interventions
- Other: Viewing of a 2-dimensional photographic libraryOther: 3-dimensional photograph with simulation
- First Posted Date
- 2017-08-15
- Last Posted Date
- 2017-08-15
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 117
- Registration Number
- NCT03250260
- Locations
- 🇬🇧
Royal Marsden Hospital, Sutton, Surrey, United Kingdom